| Target Price | $832.83 |
| Price | $815.21 |
| Potential | 2.16% |
| Number of Estimates | 24 |
| 24 Analysts have issued a price target Goldman Sachs 2026 . The average Goldman Sachs target price is $832.83. This is 2.16% higher than the current stock price. The highest price target is $942.90 15.66% , the lowest is $614.08 24.67% . | |
| A rating was issued by 32 analysts: 15 Analysts recommend Goldman Sachs to buy, 16 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Goldman Sachs stock has an average upside potential 2026 of 2.16% . Most analysts recommend the Goldman Sachs stock at Hold. |
27 Analysts have issued a sales forecast Goldman Sachs 2025 . The average Goldman Sachs sales estimate is $60.6b . This is 52.35% lower than the revenue of the last 12 months(TTM). The highest sales forecast is $62.6b 50.81% , the lowest is $56.6b 55.47% .
This results in the following potential growth metrics:
| 2024 | $127b | 17.00% |
|---|---|---|
| 2025 | $60.6b | 52.21% |
| 2026 | $63.8b | 5.33% |
| 2027 | $66.8b | 4.62% |
| 2028 | $65.8b | 1.53% |
| 2029 | $67.8b | 3.15% |
| 2030 | $68.3b | 0.64% |
| 2031 | $69.7b | 2.14% |
| 2032 | $68.4b | 1.87% |
4 Analysts have issued an Goldman Sachs EBITDA forecast 2025. The average Goldman Sachs EBITDA estimate is $19.1b . This is 18.21% lower than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $19.5b 16.62% , the lowest is $18.2b 22.19% .
This results in the following potential growth metrics and future EBITDA Margins:
| 2024 | $20.9b | 29.37% |
|---|---|---|
| 2025 | $19.1b | 8.23% |
| 2026 | $20.9b | 8.99% |
| 2024 | 16.44% | 10.57% |
|---|---|---|
| 2025 | 31.58% | 92.04% |
| 2026 | 32.68% | 3.48% |
31 Goldman Sachs Analysts have issued a net profit forecast 2025. The average Goldman Sachs net profit estimate is $15.1b . This is 4.43% lower than the net profit for the last 12 months(TTM). The highest net profit forecast is $16.0b 1.16% , the lowest is $13.6b 14.38% .
This results in the following potential growth metrics and future Net Margins:
| 2024 | $13.5b | 71.05% |
|---|---|---|
| 2025 | $15.1b | 11.93% |
| 2026 | $17.2b | 13.71% |
| 2027 | $19.3b | 12.11% |
| 2028 | $21.8b | 12.76% |
| 2029 | $22.9b | 5.46% |
| 2030 | $24.6b | 7.26% |
| 2031 | $26.1b | 6.09% |
| 2032 | $25.4b | 2.85% |
| 2024 | 10.66% | 46.19% |
|---|---|---|
| 2025 | 24.97% | 134.20% |
| 2026 | 26.96% | 7.97% |
| 2027 | 28.89% | 7.16% |
| 2028 | 33.08% | 14.50% |
| 2029 | 33.83% | 2.27% |
| 2030 | 36.05% | 6.56% |
| 2031 | 37.44% | 3.86% |
| 2032 | 37.07% | 0.99% |
31 Analysts have issued a Goldman Sachs forecast for earnings per share. The average Goldman Sachs EPS is $50.01 . This is 0.54% lower than earnings per share in the financial year 2024. The highest EPS forecast is $52.93 5.27% , the lowest is $44.80 10.90% .
This results in the following potential growth metrics and future valuations:
| 2024 | $40.54 | 77.26% |
|---|---|---|
| 2025 | $50.01 | 23.36% |
| 2026 | $56.86 | 13.70% |
| 2027 | $63.75 | 12.12% |
| 2028 | $71.88 | 12.75% |
| 2029 | $75.81 | 5.47% |
| 2030 | $81.31 | 7.25% |
| 2031 | $86.26 | 6.09% |
| 2032 | $83.80 | 2.85% |
| Current | 16.21 | 7.63% |
|---|---|---|
| 2025 | 16.30 | 0.53% |
| 2026 | 14.34 | 12.02% |
| 2027 | 12.79 | 10.81% |
| 2028 | 11.34 | 11.34% |
| 2029 | 10.75 | 5.20% |
| 2030 | 10.03 | 6.70% |
| 2031 | 9.45 | 5.78% |
| 2032 | 9.73 | 2.96% |
Based on analysts' sales estimates for 2025, the Goldman Sachs stock is valued at an EV/Sales of 20.05 and an P/S ratio of 4.03 .
This results in the following potential growth metrics and future valuations:
| Current | 9.55 | 1.81% |
|---|---|---|
| 2025 | 20.05 | 109.96% |
| 2026 | 19.04 | 5.06% |
| 2027 | 18.20 | 4.42% |
| 2028 | 18.48 | 1.56% |
| 2029 | 17.92 | 3.05% |
| 2030 | 17.80 | 0.64% |
| 2031 | 17.43 | 2.09% |
| 2032 | 17.76 | 1.90% |
| Current | 1.92 | 23.82% |
|---|---|---|
| 2025 | 4.03 | 109.86% |
| 2026 | 3.83 | 5.06% |
| 2027 | 3.66 | 4.42% |
| 2028 | 3.72 | 1.56% |
| 2029 | 3.60 | 3.05% |
| 2030 | 3.58 | 0.64% |
| 2031 | 3.51 | 2.09% |
| 2032 | 3.57 | 1.90% |
| Analyst | Rating | Action | Date |
|---|---|---|---|
| JP Morgan |
Overweight
➜
Neutral
|
Downgrade | Oct 21 2025 |
| Freedom Capital Markets |
Sell
➜
Hold
|
Upgrade | Oct 17 2025 |
| Keefe, Bruyette & Woods |
Market Perform
➜
Market Perform
|
Unchanged | Oct 17 2025 |
| Citigroup |
Neutral
➜
Neutral
|
Unchanged | Oct 16 2025 |
| Morgan Stanley |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Oct 15 2025 |
| Barclays |
Overweight
➜
Overweight
|
Unchanged | Oct 15 2025 |
| UBS |
Neutral
➜
Neutral
|
Unchanged | Oct 07 2025 |
| Analyst Rating | Date |
|---|---|
|
Downgrade
JP Morgan:
Overweight
➜
Neutral
|
Oct 21 2025 |
|
Upgrade
Freedom Capital Markets:
Sell
➜
Hold
|
Oct 17 2025 |
|
Unchanged
Keefe, Bruyette & Woods:
Market Perform
➜
Market Perform
|
Oct 17 2025 |
|
Unchanged
Citigroup:
Neutral
➜
Neutral
|
Oct 16 2025 |
|
Unchanged
Morgan Stanley:
Equal-Weight
➜
Equal-Weight
|
Oct 15 2025 |
|
Unchanged
Barclays:
Overweight
➜
Overweight
|
Oct 15 2025 |
|
Unchanged
UBS:
Neutral
➜
Neutral
|
Oct 07 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


